Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Virus Research
|
November 9, 2017
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
Ilaria Vicenti, Adele Boccuto, Alessia Giannini, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 31, 2018
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A
Ilaria Vicenti, Alessia Lai, Alessia Giannini, et al.
The Journal of Antimicrobial Chemotherapy
|
November 22, 2018
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro
Alessia Giannini, Ilaria Vicenti, Angelo Materazzi, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 19, 2020
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication
Ilaria Vicenti, Filippo Dragoni, Alessia Giannini, et al.
Antimicrobial Agents and Chemotherapy
|
October 16, 2019
Comparable <i>In Vitro</i> Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations
Francesco Saladini, Alessia Giannini, Adele Boccuto, et al.
Vaccines
|
April 23, 2022
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
Ilaria Vicenti, Monica Basso, Filippo Dragoni, et al.
The Journal of Clinical Investigation
|
October 21, 2025
Selective targeting of HIV-infected clones by cognate peptide stimulation and antiproliferative drugs
Filippo Dragoni, Joel Sop, Isha Gurumurthy, et al.
Biomolecules
|
December 24, 2021
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
Damiano Cirri, Tiziano Marzo, Iogann Tolbatov, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 22, 2021
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection
Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Life (Basel, Switzerland)
|
September 28, 2021
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects
Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Virus Research
|
November 9, 2017
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro
Ilaria Vicenti, Adele Boccuto, Alessia Giannini, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
December 31, 2018
Performance of Geno2Pheno[coreceptor] to infer coreceptor use in human immunodeficiency virus type 1 (HIV-1) subtype A
Ilaria Vicenti, Alessia Lai, Alessia Giannini, et al.
The Journal of Antimicrobial Chemotherapy
|
November 22, 2018
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro
Alessia Giannini, Ilaria Vicenti, Angelo Materazzi, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
March 19, 2020
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication
Ilaria Vicenti, Filippo Dragoni, Alessia Giannini, et al.
Antimicrobial Agents and Chemotherapy
|
October 16, 2019
Comparable <i>In Vitro</i> Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations
Francesco Saladini, Alessia Giannini, Adele Boccuto, et al.
Vaccines
|
April 23, 2022
Comparable Post-Vaccination Decay of Neutralizing Antibody Response to Wild-Type and Delta SARS-CoV-2 Variant in Healthcare Workers Recovered from Mild or Asymptomatic Infection
Ilaria Vicenti, Monica Basso, Filippo Dragoni, et al.
The Journal of Clinical Investigation
|
October 21, 2025
Selective targeting of HIV-infected clones by cognate peptide stimulation and antiproliferative drugs
Filippo Dragoni, Joel Sop, Isha Gurumurthy, et al.
Biomolecules
|
December 24, 2021
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
Damiano Cirri, Tiziano Marzo, Iogann Tolbatov, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
May 22, 2021
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection
Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Life (Basel, Switzerland)
|
September 28, 2021
BNT162b2 SARS-CoV-2 Vaccination Elicits High Titers of Neutralizing Antibodies to Both B.1 and P.1 Variants in Previously Infected and Uninfected Subjects
Ilaria Vicenti, Francesca Gatti, Renzo Scaggiante, et al.
Page
of 4